CYP 1.82% 27.0¢ cynata therapeutics limited

Ann: UK Regulatory Authority Approves Cynata GvHD Clinical Trial-CYP.AX, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,200 Posts.
    lightbulb Created with Sketch. 3885
    Here is the link to the ASX announcement from 7 April:
    http://www.asx.com.au/asxpdf/20160407/pdf/436c75n2zttf9s.pdf

    However, the final report is still due to come according to Dr Ross Macdonald:
    "We have not yet received the final report from U Mass.  We wanted to increase the number of animals in the study to further increase the statistical power and so this has led to a minor delay.  However, as you may conclude from the fact that we have already submitted our clinical trial application, the data (as previously announced) is already compelling."
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.